Because bioinformatic analysis and empirical studies of clinical samples support important roles and clinical relevance of E2F1, E2F7, and MYBL2 in GC, we explored the biological effects of genetic intervention involving these three genes in GC cell lines. This evidence concerns the gene MYBL2 and gastric cancer.